Why Is Multiple Myeloma Diagnosed Much Later in BIPOC Patients?
https://vimeo.com/552230613 How do multiple myeloma diagnosis and treatment differ in BIPOC communities? Expert Dr. Joseph Mikhael details some statistics on BIPOC myeloma patients, factors that can impact myeloma survival rates,…
Why Is Multiple Myeloma Nearly Twice As Common in BIPOC Communities?
https://vimeo.com/552230724 Why does multiple myeloma impact some BIPOC communities nearly twice as often compared to white Americans? Expert Dr. Joseph Mikhael shares factors that affect diagnosis and treatment of African…
Is MGUS More Prevalent in BIPOC Communities?
https://vimeo.com/552230799 Does the multiple myeloma precursor of monoclonal gammopathy of undetermined significance (MGUS) occur more frequently in minority (BIPOC) patients? Expert Dr. Sarah Holstein from the University of Nebraska Medical…
Tips for Myeloma Patients Deciphering Between In-Person or a Telemedicine Visit
Download Guide Download Guide See More from The Myeloma TelemEDucation Empowerment Resource Center
Telemedicine Visit Preparation Tips From Myeloma Patients to Myeloma Patients
https://vimeo.com/530603484 With the pandemic altering our conventional communication methods, how can myeloma patients be prepared for upcoming telehealth appointments? Myeloma patients Barry Marcus and Honora Miller share their top tips…
Will Telemedicine Be a Mainstay for Myeloma Patients After the Pandemic?
The Patient Empowerment Network (PEN) is fostering change toward achieving equitable healthcare for all. One resource, the Myeloma TelemEDucation Empowerment Resource Center is to significantly improve multiple myeloma patients’ and…
Is the COVID-19 Vaccine Safe for Myeloma Patients?
https://vimeo.com/530795205 Should myeloma patients get the COVID-19 Vaccine? Dr. Joshua Richter encourages all patients to get the vaccine but notes important considerations around treatment. Dr. Joshua Richter is director of…
An Expert’s Take on Promising Myeloma Treatment and Research
https://vimeo.com/530795091 Myeloma research is advancing quickly. Dr. Joshua Richter, a myeloma expert, shares his excitement about emerging treatments in development. Dr. Joshua Richter is director of Multiple Myeloma at the…
Myeloma Treatment: When Should a Clinical Trial Be Considered?
https://vimeo.com/530794984 At what point should a clinical trial be an option for myeloma treatment? Dr. Joshua Richter shares his perspective on the appropriate time to weigh clinical trial participation and…
Which Myeloma Patients Should Consider Stem Cell Transplant?
https://vimeo.com/530794878 Which myeloma patient is stem cell transplant most appropriate for? Dr. Joshua Richter reviews the factors that go into the decision, as well as the risks and benefits of…
Myeloma Treatment Decisions: What Should Be Considered?
https://vimeo.com/530794707 When deciding on a myeloma treatment, what factors affect your choice? Dr. Joshua Richter shares key considerations, the patient role in making decisions, as well as key questions to…
What Standard Testing Follows a Myeloma Diagnosis?
https://vimeo.com/530794470 What tests will you have following a myeloma diagnosis? Are there additional tests you should request? Dr. Joshua Richter provides an overview of key testing for myeloma and why…